These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9491799)

  • 1. Cisplatin-induced non-convulsive encephalopathy.
    Lyass O; Lossos A; Hubert A; Gips M; Peretz T
    Anticancer Drugs; 1998 Jan; 9(1):100-4. PubMed ID: 9491799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posterior leukoencephalopathy following cisplatin, bleomycin and vinblastine therapy for germ cell tumor of the ovary.
    Sueblinvong T; Noophun P; Pataradool K; Suwanwela N; Phanthumchinda K; Tresukosol D
    J Obstet Gynaecol Res; 2002 Apr; 28(2):99-103. PubMed ID: 12078977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome.
    Ito Y; Arahata Y; Goto Y; Hirayama M; Nagamutsu M; Yasuda T; Yanagi T; Sobue G
    AJNR Am J Neuroradiol; 1998 Mar; 19(3):415-7. PubMed ID: 9541291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Posterior reversible leukoencephalopathy syndrome caused by cisplatin: a case report].
    Romano LM; de Robles P; Ioli P; García-Saiz E
    Rev Neurol; 2005 Nov 1-15; 41(9):573-4. PubMed ID: 16254865
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinicopathological report of cisplatin encephalopathy].
    Nomura K; Ohno R; Hamaguchi K; Hata T; Hatanaka H; Matsuyama H
    Rinsho Shinkeigaku; 1995 Jan; 35(1):64-9. PubMed ID: 7781218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal encephalopathy after cisplatin therapy.
    Gorman DJ; Kefford R; Stuart-Harris R
    Med J Aust; 1989 Apr; 150(7):399-401. PubMed ID: 2469946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatinum and docetaxel for ovarian cancer in pregnancy.
    Rouzi AA; Sahly NN; Sahly NF; Alahwal MS
    Arch Gynecol Obstet; 2009 Nov; 280(5):823-5. PubMed ID: 19242705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient cortical blindness during chemotherapy (PVB) for ovarian germ cell tumor.
    Manchana T; Sirisabya N; Lertkhachonsuk R; Tresukosol D
    J Med Assoc Thai; 2006 Aug; 89(8):1265-8. PubMed ID: 17048439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ifosfamide related encephalopathy: the need for a timely EEG evaluation.
    Feyissa AM; Tummala S
    J Neurol Sci; 2014 Jan; 336(1-2):109-12. PubMed ID: 24209900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute stroke following cisplatin therapy.
    Gamble GE; Tyrrell P
    Clin Oncol (R Coll Radiol); 1998; 10(4):274-5. PubMed ID: 9764385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ileus due to extensive adhesion formation after intraperitoneal chemotherapy using cisplatinum.
    Takada S; Azukizawa S; Kubota Y; Masuda M
    Asia Oceania J Obstet Gynaecol; 1987 Dec; 13(4):445-9. PubMed ID: 3426432
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebral blindness in association with cis-platinum chemotherapy for advanced carcinoma of the fallopian tube.
    Diamond SB; Rudolph SH; Lubicz SS; Deppe G; Cohen CJ
    Obstet Gynecol; 1982 Jun; 59(6 Suppl):84S-6S. PubMed ID: 7201125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periodic lateralized epileptiform discharges: an initial electrographic pattern in reversible posterior leukoencephalopathy syndrome.
    Bhatt A; Farooq MU; Bhatt S; Majid A; Kassab MY
    Neurol Neurochir Pol; 2008; 42(1):55-9. PubMed ID: 18365964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrographic patterns in patients with posterior reversible encephalopathy syndrome and seizures.
    Kamiya-Matsuoka C; Tummala S
    J Neurol Sci; 2017 Apr; 375():294-298. PubMed ID: 28320152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment with nedaplatin in patients with ovarian cancer that recurred after platinum-containing chemotherapy: report of two cases.
    Itoh K; Yamashita T; Wakita H; Watanabe Y; Kodama K; Fujii H; Minami H; Ohtsu T; Igarashi T; Sasaki Y
    Jpn J Clin Oncol; 1998 May; 28(5):343-6. PubMed ID: 9703864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hearing loss during osteosarcoma chemotherapy: when acute ifosfamide toxicity revealed unnoticed methotrexate encephalopathy.
    Robert G; Chappé C; Taque S; Bruneau B; Gandemer V
    J Pediatr Hematol Oncol; 2014 Mar; 36(2):e100-2. PubMed ID: 24309600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of non-convulsive status epilepticus worsened Wernicke's aphasia reversely].
    Ueki Y; Terada K; Otsuka A; Kanda M; Akiguchi I
    Rinsho Shinkeigaku; 2000 Apr; 40(4):339-43. PubMed ID: 10967650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute reversible encephalopathy after repeated low-dose cisplatin infusions and concomitant radiotherapy for cancer of the tongue.
    Vihinen PP; Kätkä KM; Johansson RK; Vihinen TA; Salminen EK
    Acta Oncol; 2003; 42(3):237-9. PubMed ID: 12852700
    [No Abstract]   [Full Text] [Related]  

  • 20. Cisplatin-induced bradycardia and the importance of the QT interval.
    Schlumbrecht MP; Hehr K
    J Oncol Pharm Pract; 2015 Apr; 21(2):157-60. PubMed ID: 24557923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.